Uplizna ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

uplizna

horizon therapeutics ireland dac - inebilizumab - neuromyelitis optica - imunosupresivi - uplizna is indicated as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum disorders (nmosd) who are anti-aquaporin 4 immunoglobulin g (aqp4-igg) seropositive (see section 5.

Enspryng ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

enspryng

roche registration gmbh - satralizumab - neuromyelitis optica - imunosupresivi - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.

Fablyn ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

fablyn

dr. friedrich eberth arzneimittel gmbh - lasofoxifene tartrat - osteoporoza, postmenopavz - spolni hormoni in zdravila genitalni sistem, - zdravilo fablyn je indicirano za zdravljenje osteoporoze pri ženskah po menopavzi, pri večjem tveganju zloma. dokazano je bilo znatno zmanjšanje pogostnosti zlomov vretenc in nevretenčarjev, ne pa zlomov kolka (glejte poglavje 5. pri določanju izbiro fablyn ali drugih terapij, vključno z oestrogens, za postmenopausal ženska, bi bilo treba preučiti, simptomov menopavze, vplivi na maternice in dojk tkiv, in žilnega tveganja in koristi (glej poglavje 5.